Table I.
Association between DLX6-AS1 expression and clinicopathological characteristics of patients with non-small cell lung cancer.
| Features | n | DLX6-AS1 (mean ± SD) | t | P-value |
|---|---|---|---|---|
| Sex | 1.902 | 0.065 | ||
| Male | 39 | 3.15±3.00 | ||
| Female | 33 | 2.00±1.31 | ||
| Age, years | 0.066 | 0.197 | ||
| >65 | 35 | 2.92±2.95 | ||
| ≤65 | 37 | 2.96±2.12 | ||
| Smoking history | 1.347 | 0.075 | ||
| Yes | 37 | 3.33±2.88 | ||
| No | 35 | 2.52±2.08 | ||
| Tumor size, cm | 0.981 | 0.102 | ||
| >3 | 30 | 3.71±3.11 | ||
| ≤3 | 42 | 2.69±1.90 | ||
| Tumor differentiation | 5.294 | <0.001 | ||
| Well/moderate | 55 | 2.08±1.46 | ||
| Poor | 17 | 5.37±3.40 | ||
| TNM | 2.334 | 0.022 | ||
| I–II | 52 | 2.52±2.26 | ||
| III–IV | 20 | 4.03±2.95 | ||
| Lymphovascular invasion | 6.005 | <0.001 | ||
| Present | 16 | 5.69±2.40 | ||
| Absent | 56 | 2.15±1.98 |
DLX6-AS1, distal-less homeobox 6 antisense RNA 1.